StockData

Universe Pharmaceuticals INC (UPC) income statement

UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.52−0.04 (-2.48%)

Close on Nov 18, 2026Market cap $857.01KP/E –Yield –

Universe Pharmaceuticals INC income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2025

Gross margin
35.3%
Operating margin
-16.3%
Net margin
-20.6%
Return on equity, FY2025
-7226.1%

Financial strength

Current ratio
4.05
Debt to equity
–
Debt to assets
–
Cash to current liabilities
202.0%

Valuation

P/E ratio
–
Price to sales
0.00
Price to book
0.02
Dividend yield
–

See a number that looks wrong?